These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6301116)

  • 21. Survival of tumor allografts in rats treated with antithymocyte serum.
    Abandowitz HM; Basrur PK
    Z Naturforsch C; 1973; 28(9):631-2. PubMed ID: 4272308
    [No Abstract]   [Full Text] [Related]  

  • 22. Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital.
    Delmonico FL
    Transplant Proc; 1984 Aug; 16(4):979-82. PubMed ID: 6380062
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody response and allograft outcome with deliberate donor-specific blood transfusions.
    Mendez R; Iwaki Y; Mendez RG; Bogaard T; Self B; Konoeda Y; Terasaki PI
    Transplant Proc; 1982 Jun; 14(2):378-82. PubMed ID: 7051482
    [No Abstract]   [Full Text] [Related]  

  • 24. Critical factors in the quality control of antilymphocyte globulin (ALG).
    Thomas F; Thomas J; Millington G; Doane J; Mendez-Picon G; Lee HM
    Proc Clin Dial Transplant Forum; 1977; 7():134-40. PubMed ID: 98763
    [No Abstract]   [Full Text] [Related]  

  • 25. Multifactorial analysis of factors influencing graft survival in recipients of living related renal allografts.
    Green WF; Niblack GD; Johnson HK; Richie RE; Tallent MB; MacDonnell R; Turner B; Harbison P; Ganaway S
    Transplant Proc; 1982 Jun; 14(2):282-6. PubMed ID: 6214057
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of rabbit antithymocyte serum (RATS) and OKT3 on peripheral blood mononuclear cell subsets following renal transplantation.
    Zaltzman JS; Cole EH; Freedman J
    Clin Transplant; 1994 Dec; 8(6):516-22. PubMed ID: 7865912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of rabbit ATG serum clearance rate to circulating T-cell level, rejection onset, and survival in cardiac transplantation.
    Bieber CP; Griepp RB; Oyer PE; David LA; Stinson EB
    Transplant Proc; 1977 Mar; 9(1):1031-6. PubMed ID: 325730
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of multiple rejection episodes with ALG or ATGAM after cadaveric renal transplantation.
    Toledo-Pereya LH; Whitten J; Baskin S; McNichol L; Thavarajah K; Lin W
    Bol Asoc Med P R; 1984 Jul; 76(7):293-6. PubMed ID: 6383417
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic and therapeutic applications of monoclonal antibodies to human T-cell subsets in renal transplant recipients.
    Cosimi AB
    Urol Clin North Am; 1983 May; 10(2):289-99. PubMed ID: 6344388
    [No Abstract]   [Full Text] [Related]  

  • 31. Association of sensitization to horse antilymphocyte/thymocyte globulin with recipient age and decreased renal allograft survival rates.
    Filo RS; Book B; Pescovitz MD; Milgrom ML; Leapman SB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):577-80. PubMed ID: 8438421
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiac allograft survival in rhesus primates treated with total lymphoid irradiation and rabbit antithymocyte globulin.
    Bieber CP; Jamieson SW; Raney A; Burton NA; Bogarty S; Hoppe R; Kaplan HS; Strober S; Stinson EB
    Surg Forum; 1979; 30():284-6. PubMed ID: 120018
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-interleukin 2 monoclonal antibody following simultaneous pancreatic and kidney transplantation: a randomized trial vs rabbit antithymocyte globulin.
    Cantarovich D; Hourmant M; Dantal J; Baatard R; Le Mauff B; Jacques Y; Paineau J; Murat A; Soulillou JP
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1366. PubMed ID: 8442143
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood transfusions may induce anti-T cell receptor antibodies in renal patients.
    Fagnilli L; Singal DP
    Transplant Proc; 1982 Jun; 14(2):319-21. PubMed ID: 6180529
    [No Abstract]   [Full Text] [Related]  

  • 35. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful pancreas-renal transplantation without anti-T-cell antibody induction.
    Shapiro ME; Abrams JM; Brown RS; Steinman TI; Strom TB
    Transplant Proc; 1995 Dec; 27(6):3087-8. PubMed ID: 8539857
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys.
    Thomas JM; Carver FM; Foil MB; Hall WR; Adams C; Fahrenbruch GB; Thomas FT
    Transplantation; 1983 Jul; 36(1):104-6. PubMed ID: 6346606
    [No Abstract]   [Full Text] [Related]  

  • 38. Semi-specific immunosuppression in canine kidney allograft with I131 labelled ATG.
    Corman J; Smeesters C; Giroux L; St-Louis G; Leveille M; Lavigne CM; Lamoureux J; Jean G; Daloze P
    Transplant Proc; 1982 Dec; 14(4):656-8. PubMed ID: 6188256
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical immunosuppression with antilymphocyte globulin.
    Stiller CR
    Can Med Assoc J; 1976 Dec; 115(12):1190-1. PubMed ID: 793703
    [No Abstract]   [Full Text] [Related]  

  • 40. A prospective randomized comparison of antilymphoblast globulin versus antithymocyte globulin for cadaver kidney transplantation.
    Toledo-Pereyra LH; Bergren C; Mittal VK; Whitten JI; Baskin S; McNichol L
    Transplantation; 1985 Oct; 40(4):448-50. PubMed ID: 3901446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.